News

Filter

Current filters:

StallergenesOralair

Greer Labs debuts Oralair for the treatment of grass pollen allergy in USA

Greer Labs debuts Oralair for the treatment of grass pollen allergy in USA

06-05-2014

USA-based allergy immunotherapy products and services specialist Greer Laboratories today announced the…

Ares Life SciencesGREER LaboratoriesMarkets & MarketingOralairPharmaceuticalRespiratory and PulmonaryStallergenesUSA

US FDA approves Stallergenes’ allergy tablet Oralair

US FDA approves Stallergenes’ allergy tablet Oralair

02-04-2014

The US Food and Drug Administration has approved Oralair immunotherapy tablet from French allergen specialist…

ImmunologicalsOralairPharmaceuticalRegulationStallergenesUSA

Stallergenes' Oralair gains US FDA panel backing

Stallergenes' Oralair gains US FDA panel backing

12-12-2013

France’s Stallergenes said late yesterday that the Allergenic Products Advisory Committee (APAC) of…

GREER LaboratoriesImmunologicalsNorth AmericaOralairPharmaceuticalRegulationStallergenes

Greer Labs and Stallergenes in deal for Oralair in USA

31-10-2013

French allergy specialists Stallergenes and USA-based Greer Laboratories have signed an exclusive agreement…

GREER LaboratoriesImmunologicalsLicensingNorth AmericaOralairPharmaceuticalStallergenes

Stallergenes report growth in third quarter results

22-10-2013

French allergy specialists Stallergenes has released its third quarter results showing revenue growth…

EuropeFinancialImmunologicalsOralairPharmaceuticalStallergenes

Stallergenes adds France to roll-out of grass pollen therapy Oralair

22-11-2012

France-based Stallergenes (GENP: FP) has announced the launch in France of Oralair, its grass pollen…

EuropeMarkets & MarketingOralairPharmaceuticalRespiratory and PulmonaryStallergenes

COMPANY SPOTLIGHT

Menarini

Back to top